Report cover image

ZetaGen Therapeutics Inc - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Nov 11, 2025
Length 35 Pages
SKU # GBDT20580528

Description

SummaryZetaGen Therapeutics Inc (ZetaGen) is a clinical-stage, biopharmaceutical company dedicated to developing therapies for metastatic and primary cancers to bone and other organs. The company pipeline products including Zeta-BC-003 for the treatment of metastatic bone cancer and metastatic lytic bone lesions; Zeta-PC-004 treats metastatic prostate cancer bone lesions; and Zeta-MBC-005 targets multifocal breast cancer and metastases to the liver. It proprietary Zeta platform, which utilizes a well know small molecule via our discovery of a new molecular pathway. The company markets its products under the ZetaMet, ZetaMet-P, ZetaMast and ZetaBase brand names. ZetaGen is headquartered in Syracuse, New York, the US.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ZetaGen Therapeutics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

35 Pages
ZetaGen Therapeutics Inc Company Overview
ZetaGen Therapeutics Inc Company Snapshot
ZetaGen Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
ZetaGen Therapeutics Inc – Pipeline Analysis Overview
ZetaGen Therapeutics Inc - Key Facts
ZetaGen Therapeutics Inc - Major Products and Services
ZetaGen Therapeutics Inc Pipeline Products by Development Stage
ZetaGen Therapeutics Inc Ongoing Clinical Trials by Trial Status
ZetaGen Therapeutics Inc Pipeline Products Overview
Nalovent Bone Graft
Nalovent Bone Graft Product Overview
ZetaDent
ZetaDent Product Overview
ZetaFuse
ZetaFuse Product Overview
ZetaFuse Clinical Trial
ZetaMet
ZetaMet Product Overview
ZetaMet Clinical Trial
ZetaSet
ZetaSet Product Overview
ZetaGen Therapeutics Inc - Key Competitors
ZetaGen Therapeutics Inc - Key Employees
ZetaGen Therapeutics Inc - Locations And Subsidiaries
Head Office
Recent Developments
ZetaGen Therapeutics Inc, Recent Developments
Nov 04, 2025: Zetagen Therapeutics to Present Promising Preclinical Data at SABCS: Zeta-BC-007 Demonstrates Superior Tumoricidal Activity and Survival Benefit in Breast Cancer Model
Nov 04, 2025: Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium
Jul 28, 2025: Zetagen Therapeutics Secures Composition-Of-Matter Patents From USPTO for Novel Breast Cancer Platform
Jun 17, 2025: Zetagen Therapeutics Announces Peer-reviewed Publication of In-Vivo Dose Optimization Findings for ZetaMast (Zeta-MBC-005) for Triple Negative Breast Cancer Liver Metastases
May 06, 2025: Zetagen Therapeutics Announces Successful Completion of Enrollment in Phase 2a Clinical Study of ZetaMet (Zeta-BC-003) Metastatic Breast Cancer
Dec 10, 2024: Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST (Zeta-MBC-005) Metastatic Breast Cancer in Liver
Nov 12, 2024: Zetagen Therapeutics Announces First Patients Enrolled in Phase 2A Clinical Study of Zetamet (Zeta-Bc-003) Metastatic Breast Cancer
Sep 24, 2024: New Data Published in JAAOS Demonstrates Breakthrough Therapy ZetaFuse as a Potential Treatment for Degenerative Disc Disease in Late-Stage Cancer Patients
Oct 10, 2023: Zetagen Announces Publication in Pain Management of Early Data Using ZetaMet as a Potential Treatment for Bone Metastases
Jan 18, 2022: ZetaMet receives Health Canada Authorization for phase 2a study in treating metastatic bone lesions
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
ZetaGen Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
ZetaGen Therapeutics Inc Pipeline Products by Equipment Type
ZetaGen Therapeutics Inc Pipeline Products by Indication
ZetaGen Therapeutics Inc Ongoing Clinical Trials by Trial Status
ZetaGen Therapeutics Inc, Key Facts
ZetaGen Therapeutics Inc, Major Products and Services
ZetaGen Therapeutics Inc Number of Pipeline Products by Development Stage
ZetaGen Therapeutics Inc Pipeline Products Summary by Development Stage
ZetaGen Therapeutics Inc Ongoing Clinical Trials by Trial Status
ZetaGen Therapeutics Inc Ongoing Clinical Trials Summary
Nalovent Bone Graft - Product Status
Nalovent Bone Graft - Product Description
ZetaDent - Product Status
ZetaDent - Product Description
ZetaFuse - Product Status
ZetaFuse - Product Description
ZetaFuse - Pilot Study of ZetaFuse Bone Graft for the Treatment of Cervical Degenerative Disc Disease
ZetaMet - Product Status
ZetaMet - Product Description
ZetaMet - Feasibility Study of Zetamet Bone Graft in the Repair of Bone Defects from Metastatic Breast Cancer in the Spinal Vertebral Body: A Phase 2a, Multicenter, Open-labeled, Single-arm Study
ZetaSet - Product Status
ZetaSet - Product Description
ZetaGen Therapeutics Inc, Key Employees
Glossary
List of Figures
ZetaGen Therapeutics Inc Pipeline Products by Equipment Type
ZetaGen Therapeutics Inc Pipeline Products by Development Stage
ZetaGen Therapeutics Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us